Stephen Beard Sells 15,874 Shares of Adtalem Global Education (NYSE:CVSA) Stock

Adtalem Global Education Inc. (NYSE:CVSA) CEO Stephen Beard sold 15,874 shares of the company’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $131.25, for a total transaction of $2,083,462.50. Following the sale, the chief executive officer directly owned 429,324 shares of the company’s stock, valued at approximately $56,348,775. This trade represents a 3.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Up 0.2%

Shares of Adtalem Global Education stock opened at $128.78 on Thursday. The business’s fifty day simple moving average is $113.02. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.36. Adtalem Global Education Inc. has a twelve month low of $86.97 and a twelve month high of $156.26. The stock has a market cap of $4.38 billion, a PE ratio of 20.06, a price-to-earnings-growth ratio of 1.07 and a beta of 0.63.

Adtalem Global Education (NYSE:CVSA) last issued its quarterly earnings data on Thursday, May 7th. The company reported $1.98 EPS for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $487.03 million for the quarter. During the same quarter in the prior year, the firm earned $1.92 EPS. The business’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. Analysts forecast that Adtalem Global Education Inc. will post 8.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Wall Street Zen lowered shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research note on Saturday, May 9th. Weiss Ratings initiated coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They set a “hold (c+)” rating on the stock. Barrington Research reiterated an “outperform” rating and set a $170.00 price objective on shares of Adtalem Global Education in a research note on Friday, April 17th. Truist Financial increased their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday. Finally, Zacks Research lowered shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, March 25th. Two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Adtalem Global Education presently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.